<\/b><\/p>\n
<\/b><\/p>\n
TUESDAY, Aug. 27, 2019 (HealthDay News) — Elevated left ventricular (LV) mass is associated with an increased long-term risk for cardiovascular (CV) events, according to a study published online Aug. 27 in Radiology<\/i>.<\/p>\n
Nadine Kawel-Boehm, M.D., from the University of Washington in Seattle, and colleagues examined the long-term impact of elevated LV mass on CV events in a prospective multiethnic population. A total of 6,814 participants were enrolled between 2000 and 2002; LV mass was derived from cardiac magnetic resonance imaging at baseline enrollment. During 15 years, 4,988 participants were followed for CV events.<\/p>\n
The researchers found that 290 participants had hard coronary heart disease (CHD) events (207 myocardial infarctions [MIs] and 95 CHD deaths), 57 had other CV disease-related deaths, and 215 had heart failure. Hard CVD events (hazard ratio, 2.7 [MI, hazard ratio, 2.8; CHD death, hazard ratio, 4.3]), other CV death (hazard ratio, 7.5), and heart failure (hazard ratio, 5.4) were independently predicted by LV hypertrophy. Compared with coronary artery calcification, LV hypertrophy was a stronger predictor for CHD death, other CV death, and heart failure (z-scores: 5.4 versus 3.4, 6.8 versus 2.4, and 9.7 versus 3.2, respectively). Participants with LV hypertrophy had an increased risk for CV events in Kaplan-Meier analysis, particularly after five years.<\/p>\n
“Our results provide further evidence and motivation for aggressive treatment of individuals with LV hypertrophy,” the authors write.<\/p>\n
Abstract\/Full Text<\/a><\/p>\n Editorial (subscription or payment may be required)<\/a><\/p>\n <\/i><\/p>\n